Toronto, Ontario--(Newsfile Corp. - November 6, 2014) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm Solutions" or the "Company") today announced that it
has granted 250,000 incentive stock options to Etienne Grima, the Company's CEO,
in accordance with Mr. Grima's employment agreement. The options are exercisable
at $0.06 per share for five years from the date of grant, vest four months from
the date of grant and are subject to a four month hold period. The grant of
options is subject to the provisions of the Company's Stock Option Plan, the
policies of the TSX Venture Exchange and applicable securities laws.
About CardioComm Solutions
CardioComm Solutions' patented and proprietary technology is
used in products for recording, viewing, analyzing and storing
electrocardiograms (ECGs) for diagnosis and management of cardiac patients.
Products are sold worldwide through a combination of an external distribution
network and a North American-based sales team. The Company has earned the ISO
13485 certification, is HPB approved, HIPAA compliant, and has received FDA
market clearance for its software devices. CardioComm Solutions is headquartered
in Toronto, Ontario, Canada, with offices in Victoria, B.C.
FOR FURTHER INFORMATION PLEASE CONTACT:
Etienne Grima, Chief
Executive Officer
1-877-977-9425 x 227
investorrelations@cardiocommsolutions.com
www.cardiocommsolutions.com
Forward-looking statements
This release may contain certain forward-looking statements and
forward looking information with respect to the financial condition, results of
operations and business of CardioComm Solutions and certain of the plans and
objectives of CardioComm Solutions with respect to these items. Such statements
and information reflect management's current beliefs and are based on
information currently available to management. By their nature, forward-looking
statements and forward-looking information involve risk and uncertainty because
they relate to events and depend on circumstances that will occur in the future
and there are many factors that could cause actual results and developments to
differ materially from those expressed or implied by these forward-looking
statements and forward-looking information.
In evaluating these statements, readers should: specifically
consider risks discussed under the heading "Risk Factors" in the
Company's Annual Information Form, available at www.sedar.com; not to
place undue reliance on forward-looking statements and forward-looking
information; be aware the Company does not assume any obligation to update the
forward-looking statements and forward-looking information contained in this
Annual Information Form other than as required by applicable laws, including
without limitation Section 5.8(2) of National Instrument 51-102
(Continuous Disclosure Obligations).
Neither TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in policies of the TSX Venture Exchange)
accepts responsibility for the adequacy or accuracy of this release.
copyright (c) newsfile corp. 2014. all rights reserved